Mitochondrial function and alzheimers disease

NeuroSignals

Volumn 10, Issue 3-4, 2001, Pages 254-262

  Ojaimi, J ^a,b   Byrne, E ^b  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b ST VINCENT S HOSPITAL   (Australia)

Author keywords

Aging; Alzheimer rsquo; s disease; Brain; Mitochondria

Indexed keywords

CYTOCHROME C OXIDASE;

AEROBIC METABOLISM; AGING; ALZHEIMER DISEASE; ARTICLE; BRAIN MITOCHONDRION; ENZYME ACTIVITY; ENZYME DEFECT; FEEDBACK SYSTEM; HUMAN; MUTATION; NERVE FUNCTION; OXIDATIVE PHOSPHORYLATION;

AGING; ALZHEIMER DISEASE; BRAIN; ELECTRON TRANSPORT; ELECTRON TRANSPORT COMPLEX IV; HUMANS; MITOCHONDRIA; MODELS, BIOLOGICAL; NEURONS; OXIDATIVE PHOSPHORYLATION;

EID: 0034996104     PISSN: 1424862X     EISSN: 14248638     Source Type: Journal    
DOI: 10.1159/000046890     Document Type: Article

References (61)

1. Medvedev ZA: An attempt at a rational classification of theories of ageing. Biol Rev Camb Philos Soc 1990;65:375-398.
2. Harman D: The biological clock: The mitochondria? J Am Geriatr Soc 1972;20:145-147.
3. Miquel J, Economos AC, Fleming J, Johnson JE: Mitochondrial role in cell aging. Exp Gerontol 1980; 15: 575-591.
4. Harmon HJ, Nank S, Floyd RA: Age-dependent changes in rat brain mitochondria of synaptic and nonsynaptic origins. Mech Ageing Dev 1987;38:167-177.
5. Torii K, Sugiyama S, Takagi K, Sa-take T, Ozawa T: Age-related decreases in respiratory muscle mitochondrial function in rats. Am J Respir Cell Mol Biol 1992;6:88-92.
6. Cooper JM, Wischik C, Schapira AHV: Mitochondrial function in Alzheimer’s disease. Lancet 1993; 341:969-970.
7. Martinez M, Ferrandiz MI, De Juan E, Miquel J: Age-related changes in glutathione and lipid peroxide content in mouse synaptic mitochondria: Relationship to cytochrome c oxidase decline. Neurosci Lett 1994; 170:121-124.
8. Trounce I, Byrne E, Marzuki S: Decline in skeletal muscle mitochondrial respiratory chain function: Possible factor in ageing. Lancet 1989;vol i: 1269.
9. Ojaimi J, Masters CL, Opeskin K, McKelvie P, Byrne E: Mitochondrial respiratory chain activity in the human brain as a function of age. Mech Ageing Dev 1999; 111/1: 39-47.
10. Byrne E, Dennett X, Trounce I: Oxidative energy failure in post-mitotic cells: A major factor in senescence. Rev Neurol (Paris) 1991; 147:532-535.
11. Mecocci P, MacGarvey U, Kaufman AE, Koontz D, Shoffner JM, Wallace DC, Beal F: Oxidative damage to mitochondrial DNA shows marked age-dependent increases in human brain. Ann Neurol 1993;34: 609-616.
12. Fleming JF, Miquel J, Cottrell SF, Yengoyan LS, Economos AC: Is all aging caused by respiratory dependent injury to the mitochondrial genome. Gerontology 1982;28:44-53.
13. Linnane AW, Marzuki S, Ozawa T, Tanaka M: Mitochondrial DNA mutations as an important contributor to ageing and degenerative diseases. Lancet 1989;Vol i:642-645.
14. Wallace DC: Mitochondrial genetics: A paradigm for aging and degenerative diseases? Science 1992;256: 628-632.
15. Wallace DC, Shoffner JM, Trounce I, Brown MD, Ballinger SW, Corral-Debrinski M, Horton T, Jun AS, Lott MT: Mitochondrial DNA mutations in human degenerative diseases and aging. Biochim Biophys Acta 1995;1271:141-151.
16. Terry RD, Gonatas NK, Weiss M: Ultrastructural studies in Alzheimer’s presenile dementia. Am J Pathol 1964;44:269-297.
17. Kang J, Lemaire H-G, Unterbeck A, Salbaum JM, Masters CL, Greschik K-H, Multhaup G, Beyreuther K, Muller-Hill B: The precursor of Alzheimer’s disease amyloid A4 protein resembles a cell-surface receptor. Nature 1987;325:733-736.
18. Kidd M: Paired helical filaments in electron microscopy in Alzheimer’s disease. Nature 1963;197:192-193.
19. Brion JP, Couck AM, Passareiro E, Flament-Durand J: Neurofibrillary tangles of Alzheimer’s disease: An immunohistochemical study. J Sub-microsc Cytol 1985;1:89-96.
20. Kowall NW, Kosik KS: Axonal disruption and aberrant localization of tau protein characterize the neuro-phil pathology of Alzheimer’s disease. Ann Neurol 1987;22:639-643.
21. Mann DM, Yates PO, Marcynuik B: Some morphometric observations on the cerebral cortex and hippocampus in presenile Alzheimer’s disease, senile dementia of the Alzheimer type and Down’s syndrome in middle age. J Neurol Sci 1985;69: 139-159.
22. Lassmann H, Weiler R, Fischer P, Bancher C, Jellinger K, Floor E, Danielczyk WM, Seitelberger F, Winkler H: Synaptic pathology in Alzheimer’s disease: Immunological data for markers of synaptic and large dense core vesicles. Neuroscience 1992;46:1-8.
23. Yankner BA, Mesulam MM: P-Amyloid and the pathogenesis of Alzheimer’s disease. N Engl J Med 1991;325:1849-1857.
24. Mullaart E, Boerrigter METI, Ravid R, Swaab DF, Vjg J: Increased levels of DNA breaks in cerebral cortex of Alzheimer’s disease patients. Neu-robiol Aging 1990;11:169-173.
25. Wisniewski HM, Wegiel J, Wang KC, Lach B: Ultrastructural studies of the cells forming amyloid in cortical vessel wall in Alzheimer’s disease. Acta Neuropathol (Berl) 1992; 84:117-127.
26. Blass JP, Gibson GE: The role of oxidative abnormalities in the pathophysiology of Alzheimer’s disease. Rev Neurol (Paris) 1991; 147: 513-525.
27. Beal MF: Aging, energy, and oxidative stress in neurodegenerative disease. Ann Neurol 1995;38:357-366.
28. Blass JP, Gibson GE: The role of oxidative abnormalities in the pathophysiology of Alzheimer’s disease. Rev Neurol (Paris) 1991;147: 513-525.
29. Blass JP: Metabolic alterations common to neural and non-neural cells in Alzheimer’s disease. Hippocampus 1993;3:45-53.
30. Schapira AH: Oxidative stress and mitochondrial dysfunction in neurodegeneration. Curr Opin Neurol 1996;9/4:260-264.
31. Parker WD, Filley CM, Parks JK: Cytochrome oxidase deficiency in Alzheimer’s disease. Neurology 1990;40:1302-1303.
32. Kish SJ, Bergeron C, Raiput A, Doz-ic S, Mastrogiacomo F, Chang L-J, Wilson JM, DiStefano LM, Nobrega JN: Brain cytochrome oxidase in Alzheimer’s disease. J Neurochem 1992;59:776-779.
33. Parker WD Jr, Parks J, Filley CM, Kleinschmidt-DeMasters BK: Electron transport chain defects in Alzheimer’s disease brain. Neurology 1994;44:1090-1096.
34. Mutisya EM, Bowling AC, Beal MF: Cortical cytochrome oxidase activity is reduced in Alzheimer’s disease. J Neurochem 1994;44:1086-1090.
35. Maurer I, Zierz S, Moller H-J, Jerusalem F: Cytochrome c oxidase in Alzheimer’s disease. Neurology 1995;45:1423.
36. Chagnon P, Betard C, Robitaillle Y, Cholette A, Gauvreau D: Distribution of brain cytochrome oxidase activity in various neurodegenerative diseases. Neuroreport 1995;6:711-715.
37. Chagnon P, Robitaille Y, Gauvreau D: Brain mitochondrial DNA polymorphism and cytochrome oxidase activity in Alzheimer’s disease. Alzheimer Res 1996;2:237-242.
38. Sims NR, Finegan JM, Bowen JM, Neary D: Mitochondrial function in brain tissue in primary degenerative dementia. Brain Res 1987;436:30-38.
39. Reichmann H, Florke S, Heberstreit G, Schrubar H, Riederer P: Analyses of energy metabolism and mitochondrial genome in postmortem brain from patients with Alzheimer’s disease. J Neurol 1993;240: 377-380.
40. Schapira AH: Mitochondrial function and neurotoxicity. Curr Opin Neurol 1994;7:531-534.
41. Wong-Riley MTT: Cytochrome oxidase: An endogenous metabolic marker for neuronal activity. Trends Neurosci 1989;12:94-101.
42. Ojaimi J, Masters CL, McLean C, Opeskin K, McKelvie P, Byrne E: Irregular distribution of cytochrome c oxidase protein subunits in aging and Alzheimer’s disease. Ann Neurol 1999;46:656-660.
43. DiMauro S, Bonilla E, Davidson M, Hirano M, Schon EA: Mitochondria in neuromuscular disorders. Bio-chim Biophys Acta 1998; 1366:199-210.
44. Davis RE, Miller S, Herrnstadt C, Ghosh SS, Fahy E, Shinobu LA, Galasko D, Thal LJ, Beal MF, Howell N, Parker WD Jr: Mutations in mitochondrial cytochrome c oxidase genes segregate with late-onset Alzheimer’s disease. Proc Natl Acad Sci USA 1997;94:4526-4531.
45. Hirano M, Shtilbans A, Mayeux R, Davidson MM, DiMauro S, Knowles JA, Schon EA: Apparent mtDNA heteroplasmy in Alzheimer’s disease patients and in normals due to PCR amplification of nucleus-embedded mtDNA pseudogenes. Proc Natl Acad Sci USA 1997;94:14894-14899.
46. Wallace DC, Stugard C, Murdock D, Schurr T, Brown MD: Ancient mtDNA sequences in the human nuclear genome: A potential source of errors in identifying pathogenic mutations. Proc Natl Acad Sci USA 1997;94:14900-14905.
47. Blanchard BJ, Park T, Fripp WJ, Lerman LS, Ingram VM: A mitochondrial DNA deletion in normally ageing and Alzheimer’s brain tissue. Neuroreport 1993;4:799-802.
48. Corral-Debrinski M, Horton T, Lott MT, Shoffner JM, McKee AC, Beal MF, Graham BH, Wallace DC: Marked changes in mitochondrial DNA deletion levels in Alzheimer brains. Genomics 1994;23:471-476.
49. Terry RD, Wisniewski HM: Ultrastructure of senile dementia and of experimental analogues; in Gaitz CM (ed): Aging and the Brain. New York, Plenum Press, 1972, pp 89-116.
50. Saraiva AA, Borges MM, Madeira MD, Tavares MA, Paula-Barbosa MM: Mitochondrial abnormalities in cortical dendrites from patients with Alzheimer’s disease. J Submi-crosc Cytol 1985;17:459-464.
51. Sumpter PQ, Mann DMA, Davies CA, Yates PO, Snowden JS, Neary D: An ultrastructural analysis of the effects of accumulation of neurofibrillary tangle in pyramidal neurons of the cerebral cortex in Alzheimer’s disease. Neuropathol Appl Neuro-biol 1986;12:305-319.
52. Kadenbach B, Jarusch J, Hartman R, Merle P: Separation of mammalian cytochrome c oxidase into 13 polypeptides by sodium dodecyl sulfate-gel electrophoretic procedure. Anal Biochem 1983;129:517-521.
53. Liu S, Wong-Riley M: Disproportionate regulation of nuclear-and mitochondrial-encoded cytochrome oxidase subunit proteins by functional activity in neurons. Neuroscience 1995;67/1:197-210.
54. Nie F, Wong-Riley MT: Mitochondrial-and nuclear-encoded subunits of cytochrome oxidase in neurons: Differences in compartmental distribution, correlation with enzyme activity, and regulation by neuronal activity. J Comp Neurol 1996;373/ 1:139-155.
55. Hevner RF, Wong-Riley MTT: Brain cytochrome oxidase: Purification, antibody production and im-munohistochemical/histochemical correlations in the CNS. J Neurosci 1989;9:3884-3898.
56. Hevner RF, Wong-Riley MT: Regulation of cytochrome oxidase protein levels by functional activity in the macaque monkey visual system. J Neurosci 1990;10:1331-1340.
57. Vale RD, Schnapp BJ, Reese TS, Sheetz MP: Movement of organelles along filaments dissociated from the axoplasm of the squid giant axon. Cell 1985;40:449-454.
58. Matsuyama SS, Jarvik LF: Hypothesis: Microtubules, a key to Alzheimer’s disease. Proc Natl Acad Sci USA 1989;86:8152-8156.
59. Duara R, Grady C, Haxby J, Sun-daram M, Cutler NR, Heston L, Moore A, Schlageter N, Larson S, Rapoport SI: Positron emission tomography in Alzheimer’s disease. Neurology 1986;36:879-887.
60. Haxby JV, Grady CL, Duara R, Schlageter N, Berg G, Rapoport SI: Neocortical metabolic abnormalities precede nonmemory cognitive deficits in early Alzheimer’s-type dementia. Arch Neurol 1986;43: 882-885.
61. 31P NMR profiles of Alzheimer’s disease and multiple subcortical infarct dementia. Neurology 1989;39: 1423-1427.